HKT-500 in Adult Patients With Shoulder Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Pain
Interventions
DRUG

HKT-500 Ketoprofen Topical Patch

HKT-500 Ketoprofen Topical Patch

OTHER

Placebo Patch

Treatment with Placebo Patch

Trial Locations (35)

20003

Hisamitsu Investigator Site, Washington D.C.

20716

Hisamitsu Investigator Site, Bowie

23606

Hisamitsu Investigator Site, Newport News

27513

Hisamitsu Investigator Site, Cary

27615

Hisamitsu Investigator Site, Raleigh

27704

HIsamitsu Pharmaceutical Co., Inc., Durham

30513

Hisamitsu Investigator Site, Blue Ridge

32626

Hisamitsu Investigator Site, Chiefland

32720

Hisamitsu Investigator Site, DeLand

32763

Hisamitsu Pharmaceutical Co., Inc., Orange City

32779

Hisamitsu Investigator Site, Longwood

33324

Hisamitsu Investigator Site, Plantation

33484

Hisamitsu Investigator Site, Delray Beach

33603

Hisamitsu Investigator Site, Tampa

33609

Hisamitsu Investigator Site, Tampa

34209

Hisamitsu Investigator Site, Bradenton

34677

Hisamitsu Investigator Site, Oldsmar

34698

Hisamitsu Investigator Site, Dunedin

35209

Hisamitsu Investigator Site, Birmingham

37825

Hisamitsu Investigator Site, New Tazewell

42003

Hisamitsu Investigator Site, Paducah

43551

HIsamitsu Pharmaceutical Co., Inc., Perrysburg

43623

Hisamitsu Investigator Site, Toledo

43701

Hisamitsu Investigator Site, Zanesville

49009

Hisamitsu Investigator Site, Kalamazoo

58104

Hisamitsu Investigator Site, Fargo

58108

Hisamitsu Investigator Site, Fargo

67205

Hisamitsu Investigator Site, Wichita

77802

Hisamitsu Investigator Site, Bryan

78217

Hisamitsu Investigator Site, San Antonio

80204

Hisamitsu Investigator Site, Denver

83702

Hisamitsu Investigator Site, Boise

85283

Hisamitsu Investigator Site, Tempe

92835

Hisamitsu Investigator Site, Fullerton

08807

Hisamitsu Investigator Site, Bridgewater

All Listed Sponsors
lead

Hisamitsu Pharmaceutical Co., Inc.

INDUSTRY